News & Videos - IMMUNOME INC.

You are currently viewing all stock exchange news of the financial instrument IMMUNOME INC. regarding all markets in all languages.

> News Business Wire published a news.

Immunome Reports Second Quarter 2023 Financial Results • • Business Wire • Stocks

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update. “We believe combining Immunome and Morphimmune’s technologies represents a major step in our long-term strategy of creating a preeminent oncology therapeutics company,” stated Purnanand Sarma,...

Thank you Chart